Clinical Trial Update: Assessment of CFTR-Modulator Treatment in Cystic Fibrosis Lung Disease Using Novel Structural and Functional MRI

View source ↗

Summary

The study investigates how CFTR-modulator therapy affects lung structure and function in cystic fibrosis using novel MRI techniques. It includes healthy control…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Group 1: Healthy Controls, Group 2: Stable CF | Status: ACTIVE_NOT_RECRUITING